Can telehealth help treat opioid addiction in rural and minority areas?

NCT ID NCT07169409

Recruiting now Disease control Sponsor: Boulder Care Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study is testing whether a telehealth platform can help people with opioid use disorder, especially those in rural areas and Black and Hispanic communities, start and stay on buprenorphine treatment. Researchers will enroll 250 participants and measure how acceptable and feasible the program is. The goal is to improve access to care and reduce health disparities.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: buprenorphine
What this could lead to: If successful, this could show that telehealth is a practical way to deliver opioid use disorder treatment to underserved communities, improving access and equity.
What could go wrong: This is an early-phase study focused on feasibility and acceptability, not on proving the treatment works. The results may not apply to all settings or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPIOID-USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

opiate dependence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OPIOID-USE DISORDER

Contacts and locations

Locations

Boulder Care
RECRUITING

Portland, Oregon, 97204, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.